Corneal diameter negatively associated with central corneal thickness

Article

Corneas in microphthalmic eyes have significantly higher central corneal thickness (CCT) regardless of whether or not the patient underwent congenital cataract surgery.

Corneas in microphthalmic eyes have significantly higher central corneal thickness (CCT) regardless of whether or not the patient underwent congenital cataract surgery, according to a study published in the European Journal of Ophthalmology.

The investigation by Dr Ales Filous et al., Department of Ophthalmology for Children and Adults, Charles University, Prague, Czech Republic, involved 32 patients post-congenital cataract surgery with absolute microcornea (Group A), 13 patients with absolute microcornea without any history of eye surgery (Group B) and a control group of 124 healthy schoolchildren.

Patients with scars or corneal oedema were excluded from the study. Horizontal corneal diameter (HCD) was measured with calliper and CCT was recorded using an ultrasound pachymeter.

The findings demonstrated a significantly higher CCT of 635.13±65.35 µm and 642.31±93.07 µm, respectively in 48 eyes from group A and 16 eyes in Group B. This was compared to the mean CCT in the control group of 553.58±33.12 µm. A decrease in HCD and an increase in CCT were demonstrated by the regression curve in the microphthalmic eyes.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.